IP Library Assignment 055725/0523
Patent Assignment
Reel/Frame 055725/0523

Release of Security Interest

Recorded: 2021-03-25 Pages: 7
Assignor
TANG CAPITAL PARTNERS, LP
Executed: 2021-03-24
Assignee
HERON THERAPEUTICS, INC.
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (35)
Long-Acting Polymeric Delivery Systems
Compositions of a Polyorthoester and an Organic Acid Excipient
Emulson Formulations of Aprepitant
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Methods and Compositions for Topical Delivery of Retinoic Acid
Patent: 5,955,109 →
Application: 08/079,220 →
Peg-Poe, Peg-Poe-Peg, and Poe-Peg-Poe Block Copolymers
Patent: 5,939,453 →
Application: 09/090,648 →
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
Patent: 6,613,355 →
Application: 09/854,180 →
Publication: US 2002/0037300
Bioerodible Polyorthoesters from Dioxolane-Based Diketene Acetals
Patent: 6,590,059 →
Application: 09/854,436 →
Publication: US 2002/0168336
Method of Preparing Di(Ketene Acetals)
Patent: 6,863,782 →
Application: 10/298,188 →
Publication: US 2004/0097742
Bioerodible Poly (Orthoesters)from Dioxolane-Based Diketene Acetals
Patent: 6,822,000 →
Application: 10/330,781 →
Publication: US 2003/0130472
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Patent: 6,790,458 →
Application: 10/409,408 →
Publication: US 2003/0212148
Pharmaceutical Compositions Using Semi-Solid Delivery Vehicle
Patent: 6,861,068 →
Application: 10/765,768 →
Publication: US 2004/0156907
Bioerodible Poly(Ortho Esters) from Dioxane-Based Di(Ketene Acetals), and Block Copolymers Containing Them
Patent: 7,163,694 →
Application: 11/371,959 →
Publication: US 2006/0155101
Peg-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions
Patent: 7,456,213 →
Application: 11/392,989 →
Publication: US 2006/0235083
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Patent: 8,252,304 →
Application: 12/564,881 →
Publication: US 2010/0010104
Methods of Treating Emesis Utilizing Semi-Solid Delivery Pharmaceutical Compositions Comprising Granisetron
Patent: 8,252,305 →
Application: 13/279,938 →
Publication: US 2012/0041020
Process for Preparing a Semi-Solid Delivery Vehicle Comprising Granisetron
Patent: 8,252,306 →
Application: 13/279,949 →
Publication: US 2012/0041021
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Patent: 8,715,710 →
Application: 13/552,083 →
Publication: US 2012/0283253
Compositions of a Polyorthoester and an Aprotic Solvent
Patent: 9,744,163 →
Application: 14/210,263 →
Publication: US 2014/0275046
Compositions of a Polyorthoester and an Aprotic Solvent
Patent: 9,592,227 →
Application: 14/210,318 →
Publication: US 2014/0275145
Compositions of a Polyorthoester and an Aprotic Solvent
Patent: 9,446,036 →
Application: 14/213,658 →
Publication: US 2014/0296282
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
Application: 14/253,615 →
Publication: US 2014/0371187
Compositions and Methods for Injection of a Biodegradable Polymer-Based Delivery System
Application: 14/264,489 →
Publication: US 2014/0323517
Pharmaceutical Composition Comprising Antiemetic Compounds and Polyorthoester
Application: 14/652,070 →
Publication: US 2015/0320866
Long-Acting Polymeric Delivery Systems
Application: 14/691,464 →
Publication: US 2015/0297729
Compositions of a Polyorthoester and an Organic Acid Excipient
Application: 14/691,491 →
Publication: US 2015/0297730
Method of Treating Patients Non-Responsive to Palonosetron
Application: 14/765,179 →
Publication: US 2015/0359897
Emulsion Formulations of Aprepitant
Patent: 9,808,465 →
Application: 14/859,013 →
Publication: US 2016/0082013
Methods for Enhancing Stability of Polyorthoesters and Their Formulations
Application: 14/946,493 →
Publication: US 2016/0144039
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Patent: 9,974,742 →
Application: 15/012,532 →
Publication: US 2017/0216205
Emulsion Formulations of Aprepitant
Patent: 9,561,229 →
Application: 15/083,071 →
Publication: US 2016/0206622
Polymer-Based Compositions for Extended Release of Proteins
Application: 15/108,986 →
Publication: US 2016/0324798
Emulsion Formulations of Aprepitant
Application: 62/052,948 →
Long-Acting Polymeric Delivery Systems
Application: 62/341,557 →
Powered Delivery Device
Application: 62/360,875 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name Feb 3, 2014
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 032153/0273 →
Assignment of Assignor's Interest May 12, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 032872/0480 →
Assignment of Assignor's Interest May 22, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN; NIEMANN, JOSEPH
To: HERON THERAPEUTICS, INC.
Reel/Frame 032953/0273 →
Release of Security Interest Oct 20, 2014
From: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
To: A.P. PHARMA, INC.
Reel/Frame 033983/0126 →
Assignment of Assignor's Interest May 10, 2016
From: OTTOBONI, THOMAS B.; HAN, HAN
To: HERON THERAPEUTICS, INC.
Reel/Frame 038539/0148 →
Security Interest Aug 30, 2016
From: HERON THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS, LP
Reel/Frame 039590/0239 →
Intellectual Property Security Agreement Aug 9, 2023
From: HERON THERAPEUTICS, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 064546/0453 →
Release of Security Interest in Patents Recorded at Reel 026177/Frame 0874 Sep 27, 2023
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.)
Reel/Frame 065045/0730 →